Lung cancer (small cell)
Do you want to receive a message when there is new research about Small Cell Lung Cancer (SCLC)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you see one sentence explaining what was studied — and you'll be notified as soon as there is new research about Small cell lung cancer. View what Premium costs.
Publications and studies (3295)
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. ST-Segment Elevation Myocardial Infarction After Pegfilgrastim: Case Report and Review of Mechanistic Considerations. (2025/12/17) ♡
- Prediction of immunotherapy efficacy for pulmonary lymphoepithelioma-like carcinoma using baseline routine blood tests and serum tumor markers: a multicenter retrospective study. (2025/12/16) ♡
- Optimising Brain Metastases Management in Resource-Limited Settings: Experience with Hypofractionated Stereotactic Radiotherapy at the Salah Azaiez Institute. (2025/12/15) ♡
- Risk stratification using a nomogram model for postoperative cancer-related fatigue in elderly survivors following early-stage non-small cell lung cancer resection. (2025/12/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and Strategies. (2025/12/11) ♡
- Rongbei Maimendong Decoction Promotes Radiosensitivity of Non-Small Cell Lung Cancer Cells by Inhibiting SOD1 Expression. (2025/12/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Use of Injectable Carboxymethylcellulose Gel in the Treatment of Acquired Bronchoesophageal Fistula Secondary to Lung Cancer. (2025/12/08) ♡
- When wedge resection is good enough: Survival outcomes and nodal involvement of ground-glass-dominant stage IA non-small cell lung cancer. (2025/12/06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Multi-center Assessment of DLL3 Expression by Immunohistochemistry in Medullary Thyroid Carcinoma. (2025/12/05) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Taletrectinib as an emerging therapy for ROS1-positive non-small cell lung cancer: findings from TRUST phase 2 trials. (2025/12/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. New opportunities and challenges for nonshedder tumors. (2025/12/05) ♡
- Study of the blood-brain barrier-penetrating KRAS G12C inhibitor JMKX1899 in KRAS G12C-mutated NSCLC with brain metastases. (2025/12/05) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Engineered food-borne probiotics delivering checkpoint-inhibitor modulators. (2025/12/03) ♡
- National race-based disparities in referral to Commission on Cancer centers for lung cancer resection. (2025/12/03) ♡
- Prognostic role of prognostic nutritional index change in patients with extensive stage small cell lung cancer treated with platinum-based chemotherapy. (2025/12/02) ♡
- Quality of life and aspects related nutrition in advance stages non-small cell lung cancer patients. (2025/12/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Economics, efficacy and safety of five traditional Chinese medicine injections plus chemotherapy as adjuvant therapy for non-small cell lung cancer: A network meta-analysis. (2025/12/01) ♡
- From autoimmune inflammation to malignancy: causal genetic evidence for the RA-squamous cell lung cancer axis. (2025/12/01) ♡
- Beyond the third lumbar vertebra (L3): Thoracic computed tomography-derived muscle mass and quality assessment as a practical alternative for body composition analysis. (2025/12/01) ♡
- The dynamic nature of frailty in metastatic spine disease patients. (2025/12/01) ♡
- Retraction Note: Cyr61 suppresses the growth of non-small-cell lung cancer cells via the β-catenin-c-myc-p53 pathway. (2025/12/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prognostic utility of cachexia in lung cancer: A multicenter cohort analysis. (2025/12/01) ♡
- Impact of Baseline Body Mass Index on Immunotherapy Outcomes in Patients With Non-small-cell Lung Cancer. (2025/12/01) ♡
- Prognostic Significance of the Controlling Nutritional Status Score in Non-Small Cell Lung Cancer Patients Undergoing Neoadjuvant Therapy: Development of a Predictive Nomogram. (2025/12/01) ♡
- Development and Validation of a Nomogram for Predicting Progression-Free Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with Anlotinib. (2025/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Host-related Determinants of Response to Immunotherapy in Non-small Cell Lung Cancer: The Interplay of Body Composition, Metabolism, Sex and Immune Regulation. (2025/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. From Diagnosis, Therapy Decision-Making to Genetic Risk Assessment: The Impact of ctDNA Testing on Comprehensive Cancer Management-A Case Report. (2025/12/01) ♡
- EVALUATION OF THE DEEP INSPIRATION BREATH-HOLD TECHNIQUE TO IMPROVE DOSIMETRIC OUTCOMES IN RADIOTHERAPY FOR STAGE III NON-SMALL CELL LUNG CANCER. (2025/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. What can we expect from a combination of datopotamab deruxtecan, carboplatin, and pembrolizumab for brain metastases from non-small cell lung cancer? (2025/12/01) ♡
- T Cell Exhaustion: Phenomenon, Diagnostic and Prognostic Significance, Age-Related Features, and Correction in Lung Cancer. (2025/12/01) ♡
- The Influence of miR-802 on the Resistance of Non-Small Cell Lung Cancer and Colorectal Cancer Cells to Macrophage Cytotoxic Activity. (2025/12/01) ♡
- Preoperative C-reactive protein-augmented CONUT score as a better prognostic indicator than CONUT alone in non-small cell lung cancer across age groups. (2025/11/30) ♡
- Preoperative pulmonary function and nutrition predict survival in lung cancer patients with previous operated malignancies. (2025/11/30) ♡
- Natural compound triptolide induces caspase-3/GSDME-mediated pyroptosis by promoting ROS accumulation in small cell lung cancer. (2025/11/28) ♡
- Long-term outcomes and clinical features of stage III non-small-cell lung cancer harboring ALK rearrangements: a multicenter retrospective study of 176 patients. (2025/11/27) ♡
- Sublobar Resection in Stage I Non-Small Cell Lung Cancer With Lymphovascular Invasion. (2025/11/26) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Integrating Chinese herbal medicine in advanced lung cancer: A multicenter real-world study using target trial emulation. (2025/11/25) ♡
- Exploring the immunomodulatory mechanisms of Shiyiwei Shenqi tablets in NSCLC: N-acetylaspartate as a biomarker for modulating M1/M2 macrophage balance. (2025/11/25) ♡
- Hu-gu-xiao-ji formula reprograms macrophage polarization and suppresses tumor growth to improve non-small cell lung cancer with bone metastasis via multiple signaling pathways. (2025/11/25) ♡
- Betulin, an active component from Chinese herb birch bark, suppresses tumor angiogenesis and tumor growth by inhibiting the PAX2/VEGF-A/VEGR2 signaling pathway in non-small cell lung cancer. (2025/11/25) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Shengbai oral solution for chemotherapy-induced neutropenia and symptom management in non-small cell lung cancer: A multicenter, randomized, open-label trial. (2025/11/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dual signaling cascade regulating gut-lung axis in Interleukin-6/Interleukin-17 for NSCLC immuno pathogenesis. (2025/11/25) ♡
- PDK1 elevation was induced by epigenetic modifications of KDM3A and METTL16 to mediate TKI resistance and cancer development. (2025/11/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Broad-Spectrum RAS Inhibition in Pancreatic Ductal Adenocarcinoma: Mechanistic Advances and Therapeutic Promise. (2025/11/24) ♡
- Dietary Glycemic Index, Glycemic Load, and Risk of Lung Cancer: A Population-Based Cohort Study. (2025/11/24) ♡
- Chemotherapy-induced nausea and vomiting symptom experience in patients with non-small-cell lung cancer: A qualitative study. (2025/11/21) ♡
- Brief Report: Multi-Institution Real-World Analysis Evaluating Safety, Efficacy, and ctDNA Dynamics After Tarlatamab in Patients With Previously Treated SCLC and LCNEC. (2025/11/20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy and safety of Chinese herbal medicine granules plus chemotherapy in patients with EGFR-mutated advanced lung adenocarcinoma post-progression on first-line EGFR-TKI: study protocol for a multicenter, double-blind, randomized controlled trial. (2025/11/19) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Chinese herbal injections combined with EGFR-TKIs for intervention of non-small cell lung cancer: a systematic review and meta-analysis. (2025/11/19) ♡
- Trajectory subgroups and influencing factors of nutrition-related risk in older NSCLC patients undergoing chemotherapy. (2025/11/19) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.